Mindray’s MSCI ESG rating jumps to AA level, the highest for A-share listed companies

Mindray, a global medical solutions provider, has recently achieved an outstanding AA rating for its Environmental, Social and Governance (ESG) practices from Morgan Stanley Capital International (MSCI), a renowned international rating agency. This rating is the highest in the A-share market, signifying Mindray’s impressive advancement towards being a leader in ESG management across the globe and specifically in the medical device industry.

ESG is an investment concept and corporate evaluation standard that focuses on corporate environmental, social, and governance performance rather than financial performance. The MSCI ESG rating is one of the ESG index indicators widely recognized and valued in global capital markets. The rating results have become an important basis for the decision-making of various global investment institutions.

According to MSCI’s latest ESG rating report on Mindray, Mindray’s sustainable development practices in the social and governance areas have promoted the rating upgrade. The company’s practices in human resources management, product quality assurance, and business ethics are leading the industry.

Mindray places employees at the center of the sustainable development strategy. In 2022, the company is committed to attracting top talent from universities around the world and expert talent to build a diversified global talent team. Notably, the company has experienced an increasing number of employees worldwide for three consecutive years. Diversity, equality and inclusion represent fundamental components of Mindray’s core values. Consequently, in 2022, Mindray updated and upgraded multiple systems and management measures, with a key focus on promoting diversity throughout the entire staff. For now, Mindray has established 51 overseas subsidiary companies in 42 countries that employ 100% local employees in 29 countries. Mindray prioritizes equality in the workplace, providing equal and broad development opportunities for every individual. Mindray factually respects cultural differences existing between different countries and regions while avoiding discrimination or prejudice based on age, gender, nationality, race, skin color, or religious beliefs.

In terms of product quality and safety, MSCI stated that Mindray is in the leading position in product quality management in the industry. The company’s comprehensive quality management system integrates all business functions, including R&D, procurement, manufacturing, marketing and sales, customer service and post-marketing supervision, guaranteeing the quality and safety of all products. To ensure continuous safety, the company implements risk management at all stages of the product life cycle, integrating this process with every link in the business chain and reinforcing its sustainable development strategy.

Regarding corporate governance and business ethics, MSCI affirms the company’s protection of whistleblowers and its regular compliance audits on anti-corruption practices. Mindray advocates and practices complete honesty and trustworthiness in all business operations, strictly complying with any laws and regulations related to anti-corruption, preventing conflicts of interest, anti-fraud, anti-monopoly, and anti-unfair competition. The company conducts regular ethics audits and encourages all employees to study relevant system rules and regulations. Furthermore, Mindray invites all stakeholders, including employees, suppliers, and others, to report any illegal or disciplinary action related to the company via various channels – publicly or anonymously. The company firmly protects the rights and interests of whistleblowers and ensures that they are not subjected to any unfair or retaliatory measures.

This year, Mindray has published its fifth Sustainability Report since its listing, highlighting the company’s practices and achievements in six key areas of its sustainable development strategy. The company made an announcement of its carbon emission reduction target for the first time, committing to reduce its carbon emissions intensity by 25% by the year 2030, in comparison to the baseline from 2021, and implementing corresponding carbon reduction plans to further accelerate low-carbon transformation efforts across its operations.

Li Xiting, Chairman of Mindray, has announced the company’s continued focus on its core business and efforts to improve innovation, market expansion, and localization construction. As part of its forward-thinking approach, Mindray will always prioritize sustainable development strategies and expand collaboration with relevant stakeholders to explore sustainable pathways for the medical industry. Ultimately, the company aims to contribute to the realization of a healthier and brighter future for everyone.

About Mindray

Mindray is a leading developer, manufacturer, and supplier of medical device solutions and technologies used in healthcare facilities around the globe. We believe we can change lives by making the most advanced healthcare technology attainable for all. We do this by empowering healthcare professionals through innovative, high-value solutions that help create the next generation of life-saving tools across three primary business segments: medical imaging, patient monitoring, and life support, and in-vitro diagnostics. Mindray maintains its global headquarters in Shenzhen, China; Mindray North America is headquartered in Mahwah, New Jersey. Our Ultrasound Innovation Center is located in Silicon Valley, California, with additional facilities in major international markets around the world. For more information, please visit https://www.mindray.com/na/.